The US Food and Drug Admission (FDA) has approved its first treatment for ‘sexual desire disorder’ in women, with the new drug being hailed as a ‘Female Viagra’. The drug, praised by the FDA for its effectiveness in treating ‘generalized hypoactive sexual desire disorder (HSDD) in premenopausal women,’ has caused a stir amongst critics…
Read more
